These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22289951)

  • 41. [Precancerous lesions of the gallbladder].
    Kianmanesh R; Scaringi S; Castel B; Flamant Y; Msika S
    J Chir (Paris); 2007; 144(4):278-86. PubMed ID: 17925730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effectiveness of ursodeoxycholic acid in cholesterosis of the gallbladder].
    I'lchenko AA; Orlova IuN
    Ter Arkh; 2003; 75(2):35-8. PubMed ID: 12685388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical manifestations of cholelithiasis and its complications].
    Scheurer U
    Praxis (Bern 1994); 1995 May; 84(20):590-5. PubMed ID: 7761732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The epidemiology of gallbladder disease: observations in the Framingham Study.
    Friedman GD; Kannel WB; Dawber TR
    J Chronic Dis; 1966 Mar; 19(3):273-92. PubMed ID: 5910970
    [No Abstract]   [Full Text] [Related]  

  • 45. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy.
    Sheth S; Bedford A; Chopra S
    Am J Gastroenterol; 2000 Jun; 95(6):1402-10. PubMed ID: 10894571
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Body mass index, cigarette smoking, and other characteristics as predictors of self-reported, physician-diagnosed gallbladder disease in male college alumni.
    Sahi T; Paffenbarger RS; Hsieh CC; Lee IM
    Am J Epidemiol; 1998 Apr; 147(7):644-51. PubMed ID: 9554603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy.
    Ko CW; Beresford SA; Schulte SJ; Matsumoto AM; Lee SP
    Hepatology; 2005 Feb; 41(2):359-65. PubMed ID: 15660385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis.
    Tomida S; Abei M; Yamaguchi T; Matsuzaki Y; Shoda J; Tanaka N; Osuga T
    Hepatology; 1999 Jul; 30(1):6-13. PubMed ID: 10385632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiology of gallbladder cancer.
    Lowenfels AB; Maisonneuve P; Boyle P; Zatonski WA
    Hepatogastroenterology; 1999; 46(27):1529-32. PubMed ID: 10430289
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: a population-based study in Shanghai, China.
    Shebl FM; Andreotti G; Meyer TE; Gao YT; Rashid A; Yu K; Shen MC; Wang BS; Han TQ; Zhang BH; Stanczyk FZ; Hsing AW
    Br J Cancer; 2011 Oct; 105(9):1424-9. PubMed ID: 21915122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contributions of obesity and weight loss to gallstone disease.
    Everhart JE
    Ann Intern Med; 1993 Nov; 119(10):1029-35. PubMed ID: 8214980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Obesity related morbidity and mortality.
    Bellanger TM; Bray GA
    J La State Med Soc; 2005 Jan; 157 Spec No 1():S42-9; quiz 49. PubMed ID: 15751909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new look at the multifactoral etiology of gallbladder disease in children.
    Shafer AD; Ashley JV; Goodwin CD; Nanagas VN; Elliott D
    Am Surg; 1983 Jun; 49(6):314-9. PubMed ID: 6859671
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gallbladder cancers: associated conditions, histological types, prognosis, and prevention.
    Cariati A; Piromalli E; Cetta F
    Eur J Gastroenterol Hepatol; 2014 May; 26(5):562-9. PubMed ID: 24614695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Obesity and metabolic syndrome: pathological effects on the gastrointestinal tract.
    Feakins RM
    Histopathology; 2016 Apr; 68(5):630-40. PubMed ID: 26599607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss.
    Worobetz LJ; Inglis FG; Shaffer EA
    Am J Gastroenterol; 1993 Oct; 88(10):1705-10. PubMed ID: 8213711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Gallstones following considerable weight loss and recommendations for their prevention].
    Mijnhout GS; Smulders YM; Craanen ME
    Ned Tijdschr Geneeskd; 2004 Jan; 148(4):174-7. PubMed ID: 14974308
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gallbladder cancer: an 'Indian' disease.
    Kapoor VK; McMichael AJ
    Natl Med J India; 2003; 16(4):209-13. PubMed ID: 14606770
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Gallstones - Causes and Consequences].
    Grotemeyer KC; Lammert F
    Dtsch Med Wochenschr; 2016 Nov; 141(23):1677-1682. PubMed ID: 27855456
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Gallstones: natural course and complications].
    Blum HE
    Schweiz Rundsch Med Prax; 1992 Jul; 81(29-30):903-4. PubMed ID: 1631453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.